mycophenolate mofetil (Cellcept)

Subscribe to Selected New Research on mycophenolate mofetil

1263 relevant articles (128 outcomes, 133 trials/studies) found for this Drug

Description: mycophenolic acid that is chemically altered by the addition of morpholinoethylester; selective and reversible inhibitor of inosine monophosphate dehydrogenase

Also Known As:

Cellcept; RS 61443; RS-61443; mycophenolate mofetil hydrochloride; mycophenolic acid morpholinoethyl ester

Relationship Network

Drug Context: Research Results

Organic Chemicals: 42

Carboxylic Acids: 62

Acyclic Acids

Caproates: 2

Mycophenolic Acid: 181

mycophenolate mofetil: 1263

Lipids: 13903

Fatty Acids: 4912

Mycophenolic Acid: 181

mycophenolate mofetil: 1263

Experts

1.	Takahashi, Masafumi: 6 articles (10/2006 - 07/2003)
2.	D'Cruz, D P: 5 articles (03/2007 - 08/2002)
3.	Hughes, G R V: 5 articles (03/2007 - 08/2002)
4.	Pons, H: 5 articles (01/2007 - 09/2000)
5.	Quiroz, Y: 5 articles (01/2007 - 09/2000)
6.	Parra, G: 5 articles (01/2007 - 09/2000)
7.	Kobayashi, Eiji: 5 articles (10/2006 - 07/2003)
8.	Sanders, D B: 4 articles (10/2008 - 01/2001)
9.	Wang, Haiyan: 4 articles (09/2008 - 07/2002)
10.	Jordan, Stanley C: 4 articles (01/2008 - 12/2003)

Related Diseases

1.	Lupus Nephritis 11/01/2005 - "Short-term to intermediate-term, randomized controlled trials have shown that mycophenolate mofetil is a good option for the induction and maintenance of remission in lupus nephritis patients. " 11/24/2005 - "BACKGROUND: Since anecdotal series and small, prospective, controlled trials suggest that mycophenolate mofetil may be effective for treating lupus nephritis, larger trials are desirable. " 01/01/2008 - "The efficacy of mycophenolate mofetil in the treatment of patients with lupus nephritis has been recently established in several clinical trials. " 01/01/2004 - "Mycophenolate mofetil (MMF) is a potential new treatment for diffuse proliferative lupus nephritis. " 07/01/2009 - "The purpose of this study is to evaluate the effectiveness and safety of mycophenolate mofetil (MMF) for inducing and/or maintaining remission of lupus nephritis (LN). " Order ALL the reference details at left...
2.	Nephrotic Syndrome (Syndrome, Nephrotic) 02/01/2008 - "The results suggest that mycophenolate mofetil is effective and safe in preventing relapses in steroid-dependant nephrotic syndrome. " 09/01/2005 - "Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome." 03/01/2000 - "Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil." 10/01/2008 - "[A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children]" 11/01/2006 - "Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group." Order ALL the reference details at left...
3.	Graft vs Host Disease (Graft-Versus-Host Disease) 01/01/2006 - "We enrolled 11 patients with refractory graft-versus-host disease (GVHD) in a prospective trial evaluating the efficacy of mycophenolate mofetil (MMF). " 05/21/2009 - "We conducted a double-blind, randomized multicenter trial to determine whether the addition of mycophenolate mofetil (MMF) improves the efficacy of initial systemic treatment of chronic graft-versus-host disease (GVHD). " 04/01/2005 - "Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease." 09/01/2009 - "2008; 32:1367-1372), mycophenolate mofetil-associated injury of the upper GI tract, like that in the colon, is characterized by prominent apoptosis similar to that of mild or grade I graft-versus-host-disease injury. " 05/21/2009 - "Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease." Order ALL the reference details at left...
4.	Proteinuria 06/01/2004 - "The proteinuria improved dramatically following treatment with mycophenolate mofetil. " 01/01/2008 - "Mycophenolate mofetil as a primary therapy in MLN was successful in inducing complete remission in about 40% of MLN, particularly in patients with mild proteinuria. " 01/01/2009 - "The patient was treated with mycophenolate mofetil (1.5 g/day) with a significant improvement in proteinuria." 07/01/2008 - "Afterward, he was given mycophenolate mofetil, and proteinuria decreased to subnephrotic levels (1 g/24 hours). " 11/01/2007 - "After 3 months of treatment, mycophenolate mofetil (MMF) was added if the proteinuria was higher than 1 g/day. " Order ALL the reference details at left...
5.	Psoriasis (Pustulosis Palmaris et Plantaris) 01/01/1998 - "Psoriasis vulgaris treated successfully with mycophenolate mofetil." 01/01/2004 - "BACKGROUND: Mycophenolate mofetil (MMF) has been shown to be effective for systemic treatment of psoriasis. " 01/01/2009 - "AIMS: To compare the efficacy of ciclosporine (CsA) versus mycophenolate mofetil (MMF) in psoriasis, a randomized trial was conducted. " 05/01/2003 - "CONCLUSION: In this noncontrolled trial, the majority of patients with moderate to severe psoriasis responded to mycophenolate mofetil monotherapy with few adverse events. " 01/01/2009 - "A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cyclosporine (Ciclosporin)
2.	Cyclophosphamide (Cytoxan)
3.	Azathioprine (Imuran)
4.	Tacrolimus (Prograf)
5.	Methotrexate (Mexate)
6.	Prednisolone (Predate)
7.	Immunosuppressive Agents (Immunosuppressants)
8.	Adrenal Cortex Hormones (Corticosteroids)
9.	Sirolimus (Rapamycin)
10.	Methylprednisolone

Related Therapies and Procedures

1.	Homologous Transplantation (Allograft)
2.	Kidney Transplantation
3.	Transplantation (Transplant Recipients)
4.	Transplants (Transplant)
5.	Hematopoietic Stem Cell Transplantation

Best Treatments:
Research Summary Report
on Lupus Nephritis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 197 Outcomes
Top 200 Key Drugs and Biologics
Top 47 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>